Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
about
Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cellsDiscriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substratesCoagulation and the vessel wall in pulmonary embolismElevated expression of polymorphonuclear leukocyte elastase in breast cancer tissue is associated with tamoxifen failure in patients with advanced disease.Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall.Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules.Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases.The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis.The fibrinolytic system of the vessel wall and its role in the control of thrombosis.Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications.Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.Cell-shape regulation and matrix protein p52 content in phenotypic variants of ras-transformed rat kidney fibroblasts. Functional analysis and biochemical comparison of p52 with proteins implicated in cell-shape determination.Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1.Plasminogen activator inhibitor-type I is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture.Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium.Inhibitors of urokinase and thrombin in cultured neural cells.
P2860
Q24297830-180DF19A-2C27-47AF-883A-0E657FA93697Q24301375-EB732F47-67ED-45FB-86C7-54C60DD95C84Q27021049-580F9134-ED5D-425A-B3E6-E42B2C3FE647Q33186595-52BC7843-6F32-4C7A-BB18-2D41B29C6D3CQ34569939-DAFCEB11-3424-4EB0-82A4-0824A9A79BF9Q34632691-10E896A1-C4C9-419D-BBCA-8D1F14B42CCBQ35796413-7A9CC352-B509-4CFF-BD61-F7CA27519431Q36220034-3E600899-56C7-4F3A-86DB-28D30464B807Q36222413-92A5DA4A-3923-460A-9344-E40D1E33755FQ36222670-9B9E885E-4F2A-436E-AB95-E108981B6FCFQ36223450-67FCC0B4-B540-4A45-ABF6-209D9E915D9BQ36223752-4D4B931B-8193-4181-8DD6-3B50EE2C3774Q36722539-1429DBCB-3BFD-49CD-A7FA-CA5F2911A0DFQ37293011-2A40822A-1D67-4BCB-920B-F2C26B99A5E5Q38000918-7AD60C93-6003-4E3E-960C-E8BB4054F00EQ40475372-DFD2BDCB-5857-487B-925A-DB5F7114E865Q40743945-64CFC52B-A823-43B5-9C2C-00F2C273735AQ41696493-48C03B79-988C-4BC3-A3AA-9B4A064B8D30Q41821669-678E2AF6-434C-4311-8013-8086D5B3E894Q41919634-F879916E-E374-44CB-9D67-14E06454D867Q41956634-325FA2BE-2928-4694-B690-886A001CEE9CQ42482813-77625519-C9E8-4530-8231-196B15BC7E8EQ46420427-82F7C3AA-63B1-4026-9F07-9FF5DD2C5240
P2860
Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Association of a plasminogen a ...... ne of human endothelial cells.
@ast
Association of a plasminogen a ...... ne of human endothelial cells.
@en
type
label
Association of a plasminogen a ...... ne of human endothelial cells.
@ast
Association of a plasminogen a ...... ne of human endothelial cells.
@en
prefLabel
Association of a plasminogen a ...... ne of human endothelial cells.
@ast
Association of a plasminogen a ...... ne of human endothelial cells.
@en
P2860
P356
P1476
Association of a plasminogen a ...... ne of human endothelial cells.
@en
P2093
P2860
P304
P356
10.1083/JCB.105.6.2543
P407
P433
P577
1987-12-01T00:00:00Z